antera 3d imaging Search Results


antera 3d api 100  (Antera Therapeutics)
86
Antera Therapeutics antera 3d api 100
Antera 3d Api 100, supplied by Antera Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antera+3d+imaging/3d+antera+imaging/pmc12933354-85-2-2
Average 86 stars, based on 1 article reviews
antera 3d api 100 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
3d 3d skin analysis imaging system col α i α chain  (Antera Therapeutics)
86
Antera Therapeutics 3d 3d skin analysis imaging system col α i α chain
3d 3d Skin Analysis Imaging System Col α I α Chain, supplied by Antera Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antera+3d+imaging/3d+analyzer+imaging+skin/pm41096069-270-10-9
Average 86 stars, based on 1 article reviews
3d 3d skin analysis imaging system col α i α chain - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
3d imaging system texture  (Antera Therapeutics)
86
Antera Therapeutics 3d imaging system texture
3d Imaging System Texture, supplied by Antera Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antera+3d+imaging/3d+imaging+system+texture/pmc12473307-106-7-6
Average 86 stars, based on 1 article reviews
3d imaging system texture - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
mean sd antera 3d imaging readings au  (Antera Therapeutics)
86
Antera Therapeutics mean sd antera 3d imaging readings au
Comparison of change in pre‐marked blemish area between WDTE60N and placebo from baseline to day 60 using (A) Antera <t>3D</t> imaging analysis; (B) Blemish scale analysis. Data presented as mean and SE (Error bars represent SE). * Represents statistically significant difference ( p ‐value derived from Student's unpaired t ‐test). au, arbitrary units; SE, standard error; WDTE60N, water‐dispersible turmeric extract containing 60% natural curcuminoids.
Mean Sd Antera 3d Imaging Readings Au, supplied by Antera Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antera+3d+imaging/3d+antera+au+imaging+mean+readings+sd/pmc12448269-133-5-7
Average 86 stars, based on 1 article reviews
mean sd antera 3d imaging readings au - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
representative antera 3d images  (Antera Therapeutics)
86
Antera Therapeutics representative antera 3d images
Clinical wrinkle reductions and lifting effects after 20 weeks of treatment in the test and control groups. ( A ) Captured images of nasolabial folds <t>via</t> <t>Antera</t> <t>3D</t> CS. ( B ) Quantitative measurement of nasolabial fold depth (left) and percent change from baseline (right) in each group. ( C ) Captured images of infraorbital wrinkles via Eve V. ( D ) Quantitative measurement of infraorbital wrinkles (left) and percent change from baseline (right) in each group. ( E ) Quantitative measurement of the contour of the eye area (left) and percent change from baseline (right) in each group. ( F ) Quantitative measurement of the contour of the cheek area (left) and percent change from baseline (right) in each group. Data are presented as mean ± SD. + comparison to baseline within groups, + p < 0.05, ++ p < 0.01, ++++ p < 0.001. # comparison of change from baseline between groups at each time point, # p < 0.05, ## p < 0.01, ### p < 0.005, #### p < 0.001. ns, not significant.
Representative Antera 3d Images, supplied by Antera Therapeutics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antera+3d+imaging/3d+antera+images+representative/pmc12985180-130-0-1
Average 86 stars, based on 1 article reviews
representative antera 3d images - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


Comparison of change in pre‐marked blemish area between WDTE60N and placebo from baseline to day 60 using (A) Antera 3D imaging analysis; (B) Blemish scale analysis. Data presented as mean and SE (Error bars represent SE). * Represents statistically significant difference ( p ‐value derived from Student's unpaired t ‐test). au, arbitrary units; SE, standard error; WDTE60N, water‐dispersible turmeric extract containing 60% natural curcuminoids.

Journal: Journal of Cosmetic Dermatology

Article Title: Efficacy and Safety of an Oral Low‐Dose Water‐Dispersible Turmeric Extract Capsule on Facial Skin Health in Healthy Women: A Randomized, Double‐Blind, Placebo‐Controlled Trial

doi: 10.1111/jocd.70462

Figure Lengend Snippet: Comparison of change in pre‐marked blemish area between WDTE60N and placebo from baseline to day 60 using (A) Antera 3D imaging analysis; (B) Blemish scale analysis. Data presented as mean and SE (Error bars represent SE). * Represents statistically significant difference ( p ‐value derived from Student's unpaired t ‐test). au, arbitrary units; SE, standard error; WDTE60N, water‐dispersible turmeric extract containing 60% natural curcuminoids.

Article Snippet: In the WDTE60N group, the mean (SD) Antera 3D imaging readings (au) showed a significant reduction from baseline (64.41 [7.06]) as early as day 15, which sustained till day 60 (day 15: 63.61 [7.32], p = 0.001; day 30: 63.61 [7.58], p = 0.008; day 60: 62.93 [7.38], p = 0.001).

Techniques: Comparison, Imaging, Derivative Assay

Representative Antera 3D images of blemish areas across study visits from (A) Participant administered with WDTE60N; (B) Participant administered with Placebo. WDTE60N, water‐dispersible turmeric extract containing 60% natural curcuminoids.

Journal: Journal of Cosmetic Dermatology

Article Title: Efficacy and Safety of an Oral Low‐Dose Water‐Dispersible Turmeric Extract Capsule on Facial Skin Health in Healthy Women: A Randomized, Double‐Blind, Placebo‐Controlled Trial

doi: 10.1111/jocd.70462

Figure Lengend Snippet: Representative Antera 3D images of blemish areas across study visits from (A) Participant administered with WDTE60N; (B) Participant administered with Placebo. WDTE60N, water‐dispersible turmeric extract containing 60% natural curcuminoids.

Article Snippet: In the WDTE60N group, the mean (SD) Antera 3D imaging readings (au) showed a significant reduction from baseline (64.41 [7.06]) as early as day 15, which sustained till day 60 (day 15: 63.61 [7.32], p = 0.001; day 30: 63.61 [7.58], p = 0.008; day 60: 62.93 [7.38], p = 0.001).

Techniques:

Clinical wrinkle reductions and lifting effects after 20 weeks of treatment in the test and control groups. ( A ) Captured images of nasolabial folds via Antera 3D CS. ( B ) Quantitative measurement of nasolabial fold depth (left) and percent change from baseline (right) in each group. ( C ) Captured images of infraorbital wrinkles via Eve V. ( D ) Quantitative measurement of infraorbital wrinkles (left) and percent change from baseline (right) in each group. ( E ) Quantitative measurement of the contour of the eye area (left) and percent change from baseline (right) in each group. ( F ) Quantitative measurement of the contour of the cheek area (left) and percent change from baseline (right) in each group. Data are presented as mean ± SD. + comparison to baseline within groups, + p < 0.05, ++ p < 0.01, ++++ p < 0.001. # comparison of change from baseline between groups at each time point, # p < 0.05, ## p < 0.01, ### p < 0.005, #### p < 0.001. ns, not significant.

Journal: International Journal of Molecular Sciences

Article Title: Injectable Particulated Human Acellular Dermal Matrix Booster for Skin Restoration: An Integrated Randomized, Split-Face, Double-Blinded Clinical Trial and Preclinical Study

doi: 10.3390/ijms27052193

Figure Lengend Snippet: Clinical wrinkle reductions and lifting effects after 20 weeks of treatment in the test and control groups. ( A ) Captured images of nasolabial folds via Antera 3D CS. ( B ) Quantitative measurement of nasolabial fold depth (left) and percent change from baseline (right) in each group. ( C ) Captured images of infraorbital wrinkles via Eve V. ( D ) Quantitative measurement of infraorbital wrinkles (left) and percent change from baseline (right) in each group. ( E ) Quantitative measurement of the contour of the eye area (left) and percent change from baseline (right) in each group. ( F ) Quantitative measurement of the contour of the cheek area (left) and percent change from baseline (right) in each group. Data are presented as mean ± SD. + comparison to baseline within groups, + p < 0.05, ++ p < 0.01, ++++ p < 0.001. # comparison of change from baseline between groups at each time point, # p < 0.05, ## p < 0.01, ### p < 0.005, #### p < 0.001. ns, not significant.

Article Snippet: Representative Antera 3D images illustrate clinical changes in pigmentation area after 20 weeks in the test and control groups ( A).

Techniques: Control, Comparison

Clinical reductions in pore area and improvement in skin hydration after 20 weeks of treatment in the test and control groups. ( A ) Captured images of pores via Antera 3D CS. ( B ) Quantitative measurement of pore area (left) and percent change from baseline (right) in each group. ( C ) Quantitative measurement of skin elasticity (left) and percent change from baseline (right) in each group. Data are presented as mean ± SD. + comparison to baseline within groups, +++ p < 0.005, ++++ p < 0.001. # comparison of change from baseline between groups at each time point, # p < 0.05. ns, not significant.

Journal: International Journal of Molecular Sciences

Article Title: Injectable Particulated Human Acellular Dermal Matrix Booster for Skin Restoration: An Integrated Randomized, Split-Face, Double-Blinded Clinical Trial and Preclinical Study

doi: 10.3390/ijms27052193

Figure Lengend Snippet: Clinical reductions in pore area and improvement in skin hydration after 20 weeks of treatment in the test and control groups. ( A ) Captured images of pores via Antera 3D CS. ( B ) Quantitative measurement of pore area (left) and percent change from baseline (right) in each group. ( C ) Quantitative measurement of skin elasticity (left) and percent change from baseline (right) in each group. Data are presented as mean ± SD. + comparison to baseline within groups, +++ p < 0.005, ++++ p < 0.001. # comparison of change from baseline between groups at each time point, # p < 0.05. ns, not significant.

Article Snippet: Representative Antera 3D images illustrate clinical changes in pigmentation area after 20 weeks in the test and control groups ( A).

Techniques: Control, Comparison

Clinical reductions in pigmentation area and erythema after 20 weeks of treatment in the test and control groups. ( A ) Captured images of pigmentation via Antera 3D CS. The green eclipses indicate the areas of improvement. ( B ) Quantitative measurement of pigmentation area (left) and percent change from baseline (right) in each group. ( C ) Quantitative measurement of erythema (left) and percent change from baseline (right) in each group. Data are presented as mean ± SD. + comparison to baseline within groups, +++ p < 0.005, ++++ p < 0.001. # comparison of change from baseline between groups at each time point, # p < 0.05, ## p < 0.01. ns, not significant.

Journal: International Journal of Molecular Sciences

Article Title: Injectable Particulated Human Acellular Dermal Matrix Booster for Skin Restoration: An Integrated Randomized, Split-Face, Double-Blinded Clinical Trial and Preclinical Study

doi: 10.3390/ijms27052193

Figure Lengend Snippet: Clinical reductions in pigmentation area and erythema after 20 weeks of treatment in the test and control groups. ( A ) Captured images of pigmentation via Antera 3D CS. The green eclipses indicate the areas of improvement. ( B ) Quantitative measurement of pigmentation area (left) and percent change from baseline (right) in each group. ( C ) Quantitative measurement of erythema (left) and percent change from baseline (right) in each group. Data are presented as mean ± SD. + comparison to baseline within groups, +++ p < 0.005, ++++ p < 0.001. # comparison of change from baseline between groups at each time point, # p < 0.05, ## p < 0.01. ns, not significant.

Article Snippet: Representative Antera 3D images illustrate clinical changes in pigmentation area after 20 weeks in the test and control groups ( A).

Techniques: Control, Comparison